Clinical Trials Network - Southwest Node

southwest ctn


National Institute on Drug Abuse Clinical Trials Network (CTN)


UNM is proud to serve as a node of the National Institute on Drug Abuse Clinical Trials Network (CTN)

Principal Investigators:

Kimberly Page, PhD, MPH, MS

Associate Directors

Valerie Carrejo, MD
Snehal Bhatt, MD
Scott Tonigan, PhD
Jennifer Hettema, PhD

Funding Agency

National Institute on Drug Abuse

Division of Epidemiology, Biostatistics, and Preventive Medicine

rib-buildingDepartment of Internal Medicine
1 University of New Mexico
Albuquerque, New Mexico 87131
Phone: 505-925-4621

CTN Information

For CTN related Publications and Presentations please visit CTN Dissemination Library at

CTN Archive Page

Brain & Behavioral Health Institute and NIDA Southwest CTN Node Presents:

Targeting Solutions for Future Clinical Pain Management

September 23rd, 2021, 4:00-5:00pm

Download Flyer


Novel scFv antibodies and patient samples are being characterized in pre-clinical studies designed to target potential chronic pain therapies. The scFvs are being validated with animal behavioral and a human stem cell platform. Using a combination of electrophysiological, molecular and cell biology approaches, samples (CSF and blood) from chronic pain patients have a primary focus on how this might influence nociceptor excitability. We hope that these studies will lead to the discovery of novel targets for treating specific chronic pain conditions.